medmix AG (SWX: MEDX)
Switzerland
· Delayed Price · Currency is CHF 8.65
+0.01 (0.12%)
Nov 22, 2024, 5:30 PM CET
medmix AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 479.7 | 486.6 | 477.1 | 457.3 | 351.3 | 420.7 | Upgrade
|
| Revenue Growth (YoY) | 1.07% | 1.99% | 4.33% | 30.17% | -16.50% | -7.33% | Upgrade
|
| Cost of Revenue | 323.4 | 328.9 | 304.3 | 276.1 | 230.2 | 258.3 | Upgrade
|
| Gross Profit | 156.3 | 157.7 | 172.8 | 181.2 | 121.1 | 162.4 | Upgrade
|
| Selling, General & Admin | 115.5 | 119 | 103 | 95.6 | 81.3 | 86.2 | Upgrade
|
| Research & Development | 26.5 | 25.7 | 23.6 | 23 | 20.2 | 22.9 | Upgrade
|
| Other Operating Expenses | -2.3 | -4.3 | 5.4 | -0.2 | -0.8 | -0.5 | Upgrade
|
| Operating Expenses | 139.7 | 140.4 | 132 | 118.4 | 100.7 | 108.6 | Upgrade
|
| Operating Income | 16.6 | 17.3 | 40.8 | 62.8 | 20.4 | 53.8 | Upgrade
|
| Interest Expense | -11.9 | -10 | -6.5 | -8.1 | -7.7 | -7.3 | Upgrade
|
| Interest & Investment Income | 1.5 | 1.3 | 0.7 | - | 0.2 | 0.3 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.2 | -2.5 | -4.5 | -3.3 | 1.2 | -0.9 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.8 | -1.3 | 0.2 | -0.3 | -0.2 | - | Upgrade
|
| EBT Excluding Unusual Items | 3.2 | 4.8 | 30.7 | 51.1 | 13.9 | 45.9 | Upgrade
|
| Merger & Restructuring Charges | -2.5 | -0.9 | -1.6 | -0.3 | -3.2 | -13.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 1.3 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.8 | 2 | -15.4 | 0.1 | 0.2 | - | Upgrade
|
| Asset Writedown | -3 | -3 | -1.5 | -0.9 | -0.5 | -1.3 | Upgrade
|
| Pretax Income | 0.5 | 2.9 | 12.2 | 51.3 | 10.4 | 30.9 | Upgrade
|
| Income Tax Expense | 1.5 | 2.2 | 0.6 | 7.3 | 0.8 | 5.7 | Upgrade
|
| Earnings From Continuing Operations | -1 | 0.7 | 11.6 | 44 | 9.6 | 25.2 | Upgrade
|
| Minority Interest in Earnings | -0.8 | -0.4 | - | - | - | - | Upgrade
|
| Net Income | -1.8 | 0.3 | 11.6 | 44 | 9.6 | 25.2 | Upgrade
|
| Net Income to Common | -1.8 | 0.3 | 11.6 | 44 | 9.6 | 25.2 | Upgrade
|
| Net Income Growth | - | -97.41% | -73.64% | 358.33% | -61.90% | -51.72% | Upgrade
|
| Shares Outstanding (Basic) | 42 | 41 | 41 | 41 | 34 | - | Upgrade
|
| Shares Outstanding (Diluted) | 42 | 41 | 41 | 41 | 34 | - | Upgrade
|
| Shares Change (YoY) | 2.48% | 0.25% | -0.15% | 20.14% | - | - | Upgrade
|
| EPS (Basic) | -0.04 | 0.01 | 0.28 | 1.07 | 0.28 | - | Upgrade
|
| EPS (Diluted) | -0.04 | 0.01 | 0.28 | 1.07 | 0.28 | - | Upgrade
|
| EPS Growth | - | -97.38% | -73.81% | 281.77% | - | - | Upgrade
|
| Free Cash Flow | 24.3 | 9.7 | 11.2 | 57.5 | 8.5 | 53.5 | Upgrade
|
| Free Cash Flow Per Share | 0.58 | 0.24 | 0.27 | 1.40 | 0.25 | - | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.500 | - | - | Upgrade
|
| Gross Margin | 32.58% | 32.41% | 36.22% | 39.62% | 34.47% | 38.60% | Upgrade
|
| Operating Margin | 3.46% | 3.56% | 8.55% | 13.73% | 5.81% | 12.79% | Upgrade
|
| Profit Margin | -0.38% | 0.06% | 2.43% | 9.62% | 2.73% | 5.99% | Upgrade
|
| Free Cash Flow Margin | 5.07% | 1.99% | 2.35% | 12.57% | 2.42% | 12.72% | Upgrade
|
| EBITDA | 63.5 | 60.8 | 80.2 | 105 | 55.6 | 88.7 | Upgrade
|
| EBITDA Margin | 13.24% | 12.49% | 16.81% | 22.96% | 15.83% | 21.08% | Upgrade
|
| D&A For EBITDA | 46.9 | 43.5 | 39.4 | 42.2 | 35.2 | 34.9 | Upgrade
|
| EBIT | 16.6 | 17.3 | 40.8 | 62.8 | 20.4 | 53.8 | Upgrade
|
| EBIT Margin | 3.46% | 3.56% | 8.55% | 13.73% | 5.81% | 12.79% | Upgrade
|
| Effective Tax Rate | 300.00% | 75.86% | 4.92% | 14.23% | 7.69% | 18.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.